| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 13.844 | 39.309 | 52.730 | 57.342 | 61.115 | 72.334 | 80.476 | 91.871 | 114.706 |
| Total Income - EUR | 0 | 13.844 | 39.309 | 53.206 | 57.567 | 61.165 | 72.361 | 80.544 | 91.873 | 114.708 |
| Total Expenses - EUR | 150 | 13.294 | 23.119 | 43.405 | 52.844 | 50.672 | 49.668 | 43.261 | 49.864 | 60.434 |
| Gross Profit/Loss - EUR | -150 | 550 | 16.190 | 9.801 | 4.724 | 10.493 | 22.692 | 37.283 | 42.009 | 54.274 |
| Net Profit/Loss - EUR | -150 | 412 | 15.797 | 9.274 | 4.150 | 9.911 | 21.983 | 36.494 | 41.108 | 50.902 |
| Employees | 0 | 2 | 2 | 4 | 4 | 3 | 3 | 3 | 3 | 2 |
Check the financial reports for the company - Quercus Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 81 | 3.015 | 2.550 | 32.268 | 22.784 | 12.783 | 4.849 | 24.763 | 20.259 | 23.635 |
| Current Assets | 1.165 | 2.017 | 15.324 | 14.754 | 3.423 | 11.988 | 25.997 | 14.489 | 28.767 | 31.695 |
| Inventories | 885 | 898 | 0 | 0 | 0 | 0 | 12.230 | 0 | 112 | 851 |
| Receivables | 0 | 0 | 547 | 4.081 | 196 | 346 | 5.175 | 7.048 | 16.022 | 19.407 |
| Cash | 279 | 1.119 | 14.777 | 10.673 | 3.227 | 11.642 | 8.593 | 7.442 | 12.634 | 11.437 |
| Shareholders Funds | -105 | 308 | 16.100 | 20.328 | 5.009 | 9.961 | 22.032 | 36.542 | 41.157 | 50.950 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.350 | 4.723 | 1.774 | 26.694 | 21.256 | 14.811 | 8.825 | 2.795 | 7.902 | 4.392 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Quercus Med Srl